Extract from the Register of European Patents

EP About this file: EP1636229

EP1636229 - A1 ADENOSINE RECEPTOR ANTOGONISTS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  31.05.2013
Database last updated on 21.03.2026
Most recent event   Tooltip31.05.2013Application deemed to be withdrawnpublished on 03.07.2013  [2013/27]
Applicant(s)For all designated states
Endacea, Inc.
P.O. Box 12076
Research Triangle Park, NC 27709-2076 / US
[2006/12]
Inventor(s)01 / WILSON, Constance, N.
1112 Baslow Brook Court
Raleigh, North Carolina 27614-8866 / US
02 / PARTRIDGE, John, J.
109 Muir Lane
Chapel Hill, North Carolina 27514-1452 / US
 [2006/12]
Representative(s)Keen, Celia Mary, et al
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
[N/P]
Former [2006/12]Keen, Celia Mary, et al
J.A. Kemp & Co. 14 South Square Gray's Inn
London WC1R 5JJ / GB
Application number, filing date04785932.704.06.2004
[2006/12]
WO2004US18044
Priority number, dateUS20030476684P06.06.2003         Original published format: US 476684 P
[2006/12]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005009343
Date:03.02.2005
Language:EN
[2005/05]
Type: A2 Application without search report 
No.:EP1636229
Date:22.03.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 03.02.2005 takes the place of the publication of the European patent application.
[2006/12]
Search report(s)International search report - published on:US12.05.2005
(Supplementary) European search report - dispatched on:EP30.06.2008
ClassificationIPC:C07D473/04, C07D473/06, A61K31/522, A61P25/28, A61P25/24, A61P11/06, A61P11/00, A61P31/18, A61P37/08, A61P37/06, A61P25/16, A61P9/04
[2006/12]
CPC:
C07D473/04 (EP,US); A61P1/00 (EP); A61P11/00 (EP);
A61P11/06 (EP); A61P11/14 (EP); A61P13/00 (EP);
A61P13/12 (EP); A61P25/00 (EP); A61P25/16 (EP);
A61P25/24 (EP); A61P25/28 (EP); A61P25/30 (EP);
A61P25/36 (EP); A61P29/00 (EP); A61P3/04 (EP);
A61P3/10 (EP); A61P31/04 (EP); A61P31/12 (EP);
A61P31/14 (EP); A61P31/18 (EP); A61P37/00 (EP);
A61P37/06 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P9/00 (EP); A61P9/04 (EP); A61P9/10 (EP);
A61P9/12 (EP); C07D473/06 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/12]
Extension statesALNot yet paid
HRNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:A1-ADENOSINREZEPTORANTAGONISTEN[2006/12]
English:A1 ADENOSINE RECEPTOR ANTOGONISTS[2006/12]
French:ANTAGONISTES DU RECEPTEUR D'ADENOSINE A1[2006/12]
Entry into regional phase05.01.2006National basic fee paid 
05.01.2006Search fee paid 
05.01.2006Designation fee(s) paid 
05.01.2006Examination fee paid 
Examination procedure05.01.2006Amendment by applicant (claims and/or description)
05.01.2006Examination requested  [2006/12]
17.12.2010Despatch of a communication from the examining division (Time limit: M06)
27.06.2011Reply to a communication from the examining division
25.08.2011Despatch of a communication from the examining division (Time limit: M06)
10.01.2012Reply to a communication from the examining division
03.02.2012Despatch of a communication from the examining division (Time limit: M06)
08.08.2012Reply to a communication from the examining division
30.08.2012Despatch of a communication from the examining division (Time limit: M04)
10.01.2013Application deemed to be withdrawn, date of legal effect  [2013/27]
15.02.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2013/27]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  17.12.2010
Fees paidRenewal fee
05.01.2006Renewal fee patent year 03
14.06.2007Renewal fee patent year 04
28.03.2008Renewal fee patent year 05
16.06.2009Renewal fee patent year 06
11.06.2010Renewal fee patent year 07
13.06.2011Renewal fee patent year 08
14.06.2012Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[E] WO2004110379  (ENDACEA INC et al.) [E] 1-13 * the whole document *
 [E] WO2004074247  (ENDACEA INC et al.) [E] 1,13 * the whole document *
ExaminationWO0177110
 US2003114469
 WO9822465
 US5338743
   BEAUGLEHOLE, A.R.; BAKER, S.P.; SCAMMELS, P.J.: "New Irreversible Adenosine A1 Antagonists Based on FSCPX", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, no. 12, 2002, pages 3179 - 3182, ISSN: 0960-894X
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.